ABSTRACT
The prognostic relevance of hypertension in heart and liver transplant recipients is not yet clearly established. Myers and co-workers could not establish systemic arterial BP as predictor of survival after heart transplantation (1). Also, in liver transplant recipients, Guckelberger and co-workers did not observe BP as an independent predictor of cardiovascular outcome (2). However, from the available evidence, the management of hypertension in solid organ transplant recipients does not differ significantly with regards to the transplanted organ. Effective BP control is mandatory not only in kidney transplant recipients but also in other solid organ transplant recipients. Ojo et al. recently reported a cumulative 5-year incidence of end-stage renal disease in nonrenal solid organ transplant recipients between 7% and 21% depending on the organ transplanted (3). A significant risk factor for renal failure was hypertension, and the occurrence of renal failure was associated with excess mortality (relative risk 4.55).
